Echinocandins: Production and applications

Applied Microbiology and Biotechnology

Volumn 97, Issue 8, 2013, Pages 3267-3284

  Emri, Tamás ^a   Majoros, László ^b   Tóth, Viktória ^a   Pócsi, István ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

1,3 Glucan synthase; Echinocandin resistance; Natural echinocandins; Non ribosomal peptide synthase; Paradoxical growth; Semisynthetic echinocandins

Indexed keywords

ECHINOCANDIN; INDUSTRIAL PRODUCTION; NATURAL ECHINOCANDINS; SEMI-SYNTHETIC DERIVATIVES; SEMISYNTHETIC ECHINOCANDINS; STRUCTURAL DIVERSITY; STRUCTURE ACTIVITY RELATIONSHIPS; SYNTHASES;

BIOCHEMISTRY; FUNGI;

PEPTIDES;

1,3 BETA GLUCAN SYNTHASE; ANIDULAFUNGIN; CASPOFUNGIN; ECHINOCANDIN B; MICAFUNGIN; NONRIBOSOMAL PEPTIDE SYNTHETASE; PNEUMOCANDIN B0; PNEUMOCANDIN DERIVATIVE; UNCLASSIFIED DRUG;

BIOSAFETY; DATA ACQUISITION; DRUG; ENZYME; ENZYME ACTIVITY; INDUSTRIAL PRODUCTION; PEPTIDE;

CANDIDA GLABRATA; COMPETITIVE INHIBITION; COST EFFECTIVENESS ANALYSIS; FUNGAL CELL WALL; FUNGICIDAL ACTIVITY; FUNGUS ISOLATION; GENE CLUSTER; INDUSTRIAL PRODUCTION; REVIEW;

ANTIFUNGAL AGENTS; BIOSYNTHETIC PATHWAYS; BIOTECHNOLOGY; DRUG RESISTANCE, FUNGAL; ECHINOCANDINS; HUMANS; MYCOSES; TECHNOLOGY, PHARMACEUTICAL;

ASCOMYCOTA; ASPERGILLUS; CANDIDA; CANDIDA GLABRATA; FUNGI;

EID: 84876679185     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-013-4761-9     Document Type: Review

References (176)

1. Adefarati AA, Giacobbe RA, Hensens OD, Tkacz JS (1991) Biosynthesis of L-671,329, an echinocandin-type antibiotic produced by Zalerion arboricola: origins of some of the unusual amino acids and the dimethylmyristic acid side-chain. J Am Chem Soc 113:3542-3545
2. Adefarati AA, Hensens OD, Jones ET, Tkacz JS (1992) Pneumocandins from Zalerion arboricola V. Glutamic acid- and leucinederived amino acids in pneumocandin Ao (l-671,329) and distinct origins of the substituted proline residues in pneumocandins Ao and Bo. J Antibiot 45:1953-1957
3. Arendrup MC, Perkhofer S, Howard SJ, Garcia-Effron G, Vishukumar A, Perlin D, Lass-Florl C (2008) Establishing in vitro-in vivo correlations for Aspergillus fumigatus: the challenge of azoles versus echinocandins. Antimicrob Agents Chemother 52:3504-3511
4. Arikan S, Lozano-Chiu M, Paetznick V, Rex JH (2001) In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates. Antimicrob Agents Chemother 45:327-330
5. Aszodi J, Fauveau P, Melon-Manguer D, Ehlersb E, Schioa L (2002) Synthesis of new echinocandin derivatives via a diol-keto transposition. Tetrahedron Lett 43:2953-2956
6. Bachmann SP, VandeWalle K, Ramage G, Patterson TF, Wickes BL, Graybill JR, López-Ribot JL (2002a) In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob Agents Chemother 46:3591-3596
7. Bachmann SP, Patterson TF, Lopez-Ribot JL (2002b) In vitro activity of caspofungin (MK-0991) against Candida albicans clinical isolates displaying different mechanisms of azole resistance. J Clin Microbiol 40:2228-2230
8. Bacic A, Fincher GB, Stone BA (2009) Chemistry, biochemistry, and biology of 1-3 beta glucans and related polysaccharides. Academic Press, Amsterdam
9. Bal AM (2010) The echinocandins: three useful choices or three too many? Int J Antimicrob Agents 35:13-18
10. Balashov SV, Park S, Perlin DS (2006) Assessing resistance to the echinocandin antifungal drug caspofungin in Candida albicans by profiling mutations in FKS1. Antimicrob Agents Chemother 50:2058-2063
11. Balkovec JM, Black RM, Abruzzo GK, Bartizal K, Dreikorn S, Nollstadt K (1993) Pneumocandin antifungal lipopeptides. The phenolic hydroxyl is required for 1,3- β-D-glucan synthesis inhibition. Bioorg Med Chem Lett 3:2039-2042
12. Bayegan S, Szilágyi J, Kemény-Beke Á, Földi R, Kardos G, Gesztelyi R, Juhasz B, Adnan A, Majoros L (2011) Efficacy of a single 6 mg/kg versus two 3 mg/kg caspofungin doses for treatment of disseminated candidiasis caused by Candida albicans in a neutropenic mouse model. J Chemother 23:107-109
13. Ben-Ami R, Garcia-Effron G, Lewis RE, Gamarra S, Leventakos K, Perlin DS, Kontoyiannis DP (2011) Fitness and virulence costs of Candida albicans fks1 hot spot mutations associated with echinocandin resistance. J Infect Dis 204:626-635
14. Benz F, Knüsel F, Nüesch J, Treichler H, Voser W, Nyfeler R, Keller-Schierlein W (1974) Stoffwechselprodukte von Mikroorganismen 143. Mitteilung. Echinocandin B, ein neuartiges Polypeptid-Antibioticum aus Aspergillus nidulans var. echinulatus: Isolierung und Bausteine. Helv Chim Acta 57:2459-2477
15. Betts RF, Nucci M, Talwar D, Gareca M, Queiroz-Telles F, Bedimo RJ, Herbrecht R, Ruiz-Palacios G, Young JA, Baddley JW, Strohmaier KM, Tucker KA, Taylor AF, Kartsonis NA; Caspofungin High-Dose Study Group (2009) A Multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis. Clin Infect Dis 48:1676-1684
16. Bills GF, Platas G, Peláez F, Masurekar P (1999) Reclassification of a pneumocandin-producing anamorph, Glarea lozoyensis gen. et sp. nov., previously identified as Zalerion arboricola. Mycol Res 103:179-192
17. Boeck LD, Kastner RE (1981) Method of producing the A-30912 antibiotics. US Pat 4:288-549
18. Bouffard FA, Zambias RA, Dropinski JF, Balkovec JM, Hammond ML, Abruzzo GK, Bartizal KF, Marrinan JA, Kurtz MB, McFadden DC, Nollstadt KH, Powles MA, Schmatz DM (1994) Synthesis and antifungal activity of novel cationic pneumocandin B0 derivatives. J Med Chem 37:222-225
19. Bowman JC, Hicks PS, Kurtz MB, Rosen H, Schmatz DM, Liberator PA, Douglas CM (2002) The antifungal echinocandin caspofungin acetate kills growing cells of Aspergillus fumigatus in vitro. Antimicrob Agents Chemother 46:3001-3012
20. Bryskier A (2005) Peptide antibiotics. In: Bryskier A (ed) Antimicrobial agents: Antibacterials and antifungals. ASM Press, Washington, pp 826-879
21. Cacho RA, Jiang W, Chooi YH, Walsh CT, Tang Y (2012) Identification and characterization of the echinocandin B biosynthetic gene cluster from Emericella rugulosa NRRL 11440. J Am Chem Soc 134:16781-16790
22. Calvo E, Pastor FJ, Mayayo E, Guarro J (2011) Efficacy of anidulafungin against Aspergillus niger in vitro and in vivo. Int J Antimicrob Agents 38:360-363
23. Calvo E, Pastor FJ, Salas V, Mayayo E, Guarro J (2012) Combined therapy of voriconazole and anidulafungin in murine infections by Aspergillus flavus. Mycopathologia 173:251-257
24. Cassone A, Mason R, Kerridge D (1981) Lysis of growing yeast-form cells of Candida albicans by echinocandin: a cytological study. Sabouraudia 19:97-110
25. Chamilos G, Lewis RE, Albert N, Kontoyiannis DP (2007) Paradoxical effect of echinocandins across Candida species in vitro: evidence for echinocandin-specific and Candida species-related differences. Antimicrob Agents Chemother 51:2257-2259
26. Chandrasekar PH, Sobel JD (2006) Micafungin: a new echinocandin. Clin Infect Dis 42:1171-1178
27. Chen SC, Slavin MA, Sorrell TC (2011) Echinocandin antifungal drugs in fungal infections: a comparison. Drugs 71:11-41
28. Clancy CJ, Huang H, Cheng SH, Derendorf H, Nguyen MH (2006) Characterizing the effects of caspofungin on Candida albicans, Candida parapsilosis, and Candida glabrata isolates by simultaneous time-kill and postantifungal-effect experiments. Antimicrob Agents Chemother 50:2569-2572
29. Clemons KV, Espiritu M, Parmar R, Stevens DA (2006) Assessment of paradoxical effect of caspofungin in therapy of candidiasis. Antimicrob Agents Chemother 50:1293-1297
30. Connors N, Pollard D (2004) Pneumocandin B0 production by fermentation of the fungus Glarea lozoyensis. In: Zhiqiang A (ed) Handbook of Industrial Mycology. Marcel Dekker, New York, pp 515-538
31. Connors N, Petersen L, Hughes R, Saini K, Olewinski R, Salmon P (2000) Residual fructose and osmolality affect the levels of pneumocandins B0 and C0 produced by Glarea lozoyensis. Appl Microbiol Biotechnol 54:814-818
32. Cushion MT, Collins MS (2011) Susceptibility of Pneumocystis to echinocandins in suspension and biofilm cultures. Antimicrob Agents Chemother 55:4513-4518
33. De Rosa FG, Garazzino S, Pasero D, Di Perri G, Ranieri VM (2009) Invasive candidiasis and candidemia: new guidelines. Minerva Anestesiol 75:453-458
34. Debono M, Gordee RS (1994) Antibiotics that inhibit fungal cell wall development. Annu Rev Microbiol 48:471-497
35. Debono M, Abbott BJ, Turner JR, Howard LC, Gordee RS, Hunt AS, Barnhart M, Molloy RM, Willard KE, Fukuda D, Butler TF, Zeckner DJ (1988) Synthesis and evaluation of LY121019, a member of a series of semisynthetic analogues of the antifungal lipopeptide echinocandin B. Ann N Y Acad Sci 544:152-167
36. Debono M, Abbott BJ, Fukuda DS, Barnhart M, Willard KE, Molloy RM, Michel KH, Turner JR, Butler TF, Hunt AH (1989) Synthesis of new analogs of echinocandin B by enzymatic deacylation and chemical reacylation of the echinocandin B peptide: synthesis of the antifungal agent cilofungin (LY121019). J Antibiot 42:389-397
37. Debono M, Turner WW, LaGrandeur L, Burkhardt FJ, Nissen JS, Nichols KK, Rodriguez MJ, Zweifel MJ, Zeckner DJ, Gordee RS, Tang J, Parr TR (1995) Semisynthetic chemical modification of the antifungal lipopeptide echinocandin B (ECB): structure-activity studies of the lipophilic and geometric parameters of polyarylated acyl analogs of ECB. J Med Chem 38:3271-3281
38. Dichtl K, Helmschrott C, Dirr F, Wagener J (2012) Deciphering cell wall integrity signalling in Aspergillus fumigatus: identification and functional characterization of cell wall stress sensors and relevant Rho GTPases. Mol Microbiol 83:506-519
39. DiDone L, Oga D, Krysan DJ (2011) A novel assay of biofilm antifungal activity reveals that amphotericin B and caspofungin lyse Candida albicans cells in biofilms. Yeast 28:561-568
40. Douglas CM (2006) Understanding the microbiology of the Aspergillus cell wall and the efficacy of caspofungin. Med Mycol 44:S95-S99
41. Douglas CM, D'Ippolito JA, Shei GJ, Meinz M, Onishi J, Marrinan JA, Li W, Abruzzo GK, Flattery A, Bartizal K, Mitchell A, Kurtz MB (1997) Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors. Antimicrob Agents Chemother 41:2471-2479
42. Drouhet E, Dupont B, Improvisi L, Lesourd M, Prevost MC (1990) Activity of cilofungin (LY 121019), a new lipopeptide antibiotic, on the cell wall and cytoplasmic membrane of Candida albicans. Structural modifications in scanning and transmission electron microscopy. J Med Vet Mycol 28:425-436
43. Espinel-Ingroff A (2003) In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature. Rev Iberoam Micol 20:121-136
44. Földi R, Szilágyi J, Kardos G, Berényi R, Kovács R, Majoros L (2012) Effect of 50 % human serum on the killing activity of micafungin against eight Candida species using time-kill methodology. Diagn Microbiol Infect Dis 73:338-342
45. Fortwendel JR, Juvvadi PR, Perfect BZ, Rogg LE, Perfect JR, Steinbach WJ (2010) Transcriptional regulation of chitin synthases by calcineurin controls paradoxical growth of Aspergillus fumigatus in response to caspofungin. Antimicrob Agents Chemother 54:1555-1563
46. Fujie A (2007) Discovery of micafungin (FK463): a novel antifungal drug derived from a natural product lead. Pure Appl Chem 79:603-614
47. Fujie A, Iwamoto T, Sato B, Muramatsu H, Kasahara C, Furuta T, Hori Y, Hino M, Hashimoto S (2001) FR131535, a novel water-soluble echinocandin-like lipopeptide: synthesis and biological properties. Bioorg Med Chem Lett 11:399-402
48. Ganesan LT, Manavathu EK, Cutright JL, Alangaden GJ, Chandrasekar PH (2004) In-vitro activity of nikkomycin Z alone and in combination with polyenes, triazoles or echinocandins against Aspergillus fumigatus. Clin Microbiol Infect 10:961-966
49. Gao X, Haynes SW, Ames BD, Wang P, Vien L, Walsh CT, Tang Y (2012) Cyclization of fungal nonribosomal peptides by a terminal condensation-like domain. Nat Chem Biol 8:823-830
50. Garcia-Effron G, Katiyar SK, Park S, Edlind TD, Perlin DS (2008) A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility. Antimicrob Agents Chemother 52:2305-2312
51. Garcia-Effron G, Lee S, Park S, Cleary JD, Perlin DS (2009a) Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-(beta)-D-glucan synthase: implication for the existing susceptibility breakpoint. Antimicrob Agents Chemother 53:3690-3699
52. Garcia-Effron G, Park S, Perlin DS (2009b) Correlating echinocandin MIC and kinetic inhibition of fks1 mutant glucan synthases for Candida albicans: implications for interpretive breakpoints. Antimicrob Agents Chemother 53:112-122
53. Garcia-Effron GS, Park S, Perlin DS (2011) Improved detection of Candida sp. fks hot spot mutants by using the method of the CLSI M27-A3 Document with the addition of bovine serum albumin. Antimicrob Agents Chemother 55:2245-2255
54. Gardiner RE, Souteropoulos P, Park S, Perlin DS (2005) Characterization of Aspergillus fumigatus mutants with reduced susceptibility to caspofungin. Med Mycol 43:S299-S305
55. Geiser DM, Klich MA, Frisvad JC, Peterson SW, Varga J, Samson RA (2007) The current status of species recognition and identification in Aspergillus. Stud Mycol 59:1-10
56. Ghannoum M, D'Angelo M (2005) Anidulafungin: a potent antifungal that targets candida and aspergillus. Infect Dis Clin Prac 13:165-178
57. Gil C, Pérez-Diaz R, Nombela C (1994) Inhibitory and morphological effects of several antifungal agents on three types of Candida albicans morphological mutants. J Med Vet Mycol 32:151-162
58. Gordee RS, Zeckner DJ, Howard LC, Alborn WE Jr, Debono M (1988) Anti-Candida activity and toxicology of LY121019, a novel semisynthetic polypeptide antifungal antibiotic. Ann N Y Acad Sci 544:294-309
59. Hansen DB, Bumpus SB, Aron ZD, Kelleher NL, Walsh CT (2007) The loading module of mycosubtilin: an adenylation domain with fatty acid selectivity. J Am Chem Soc 129:6366-6367
60. Hao B, Cheng S, Clancy CJ, Nguyen MH (2012) Caspofungin kills Candida albicans by causing both cellular apoptosis and necrosis. Antimicrob Agents Chemother. doi: 10.1128/AAC.01366-12
61. Hensens OD, Liesch JM, Zink DL, Smith JL, Wichmann CF, Schwartz RE (1992) Pneumocandins from Zalerion arboricola. III. Structure elucidation. J Antibiot 45:1875-1885
62. Hino M, Fujie A, Iwamoto T, Hori Y, Hashimoto M, Tsurumi Y, Sakamoto K, Takase S, Hashimoto S (2001) Chemical diversity in lipopeptide antifungal antibiotics. J Ind Microbiol Biotechnol 27:157-162
63. Hodges RL, Hodges DW, Goggans K, Xuei X, Skatrud P, McGilvray D (1994) Genetic modification of an echinocandin B-producing strain of Aspergillus nidulans to produce mutants blocked in sterigmatocystin biosynthesis. J Ind Microbiol 13:372-381
64. Hodges RL, Kelkar HS, Xuei X, Skatrud PL, Keller NP, Adams TH, Kaiser RE, Vinci VA, McGilvray D (2000) Characterization of an echinocandin B-producing strain blocked for sterigmatocystin biosynthesis reveals a translocation in the stcW gene of the aflatoxin biosynthetic pathway. J Ind Microbiol Biotechnol 25:333-341
65. Hoffmann D, Hevel JM, Moore RE, Moore BS (2003) Sequence analysis and biochemical characterization of the nostopeptolide A biosynthetic gene cluster from Nostoc sp. GSV224. Gene 311:171-180
66. Hormigo D, de la Mata I, Acebal C, Arroyo M (2010) Immobilized aculeacin A acylase from Actinoplanes utahensis: characterization of a novel biocatalyst. Bioresour Technol 101:4261-4268
67. Howard SJ, Arendrup MC (2011) Acquired antifungal drug resistance in Aspergillus fumigatus: epidemiology and detection. Med Mycol 49:S90-S95
68. Imtiaz T, Lee KK, Munro CA, Maccallum DM, Shankland GS, Johnson EM, Macgregor MS, Bal AM (2012) Echinocandin resistance due to simultaneous FKS mutation and increased cell wall chitin in a Candida albicans bloodstream isolate following brief exposure to caspofungin. J Med Microbiol 61:1330-1334
69. Inokoshi J, Takeshima H, Ikeda H, Omura S (1992) Cloning and sequencing of the aculeacin A acylase-encoding gene from Actinoplanes utahensis and expression in Streptomyces lividans. Gene 119:29-35
70. Ishihara S, Hirata A, Nogami S, Beauvais A, Latge JP, Ohya Y (2007) Homologous subunits of 1,3-beta-glucan synthase are important for spore wall assembly in Saccharomyces cerevisiae. Eukaryot Cell 6:143-156
71. Iwamoto T, Fujie A, Sakamoto K, Tsurumi Y, Shigematsu N, Yamashita M, Hashimoto S, Okuhara M, Kohsaka M (1994) WF11899A, B and C, novel antifungal lipopeptides, I: taxonomy, fermentation, isolation and physico-chemical properties. J Antibiot 47:1084-1091
72. Johnson ME, Katiyar SK, Edlind TD (2011) New Fks hot spot for acquired echinocandin resistance in Saccharomyces cerevisiae and its contribution to intrinsic resistance of Scedosporium species. Antimicrob Agents Chemother 55:3774-3781
73. Kanafani ZA, Perfect JR (2008) Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact. Clin Infect Dis 46:120-128
74. Kanasaki R, Abe F, Kobayashi M, Katsuoka M, Hashimoto M, Takase S, Tsurumi Y, Fujie A, Hino M, Hashimoto S, Hori Y (2006a) FR220897 and FR220899, novel antifungal lipopeptides from Coleophoma empetri no. 14573. J Antibiot 59:149-157
75. Kanasaki R, Kobayashi M, Fujine K, Sato I, Hashimoto M, Takase S, Tsurumi Y, Fujie A, Hino M, Hashimoto S, Hori Y (2006b) FR227673 and FR190293, novel antifungal lipopeptides from Chalara sp. No. 22210 and Tolypocladium parasiticum No. 16616. J Antibiot 59:158-167
76. Kanasaki R, Sakamoto K, Hashimoto M, Takase S, Tsurumi Y, Fujie A, Hino M, Hashimoto S, Hori Y (2006c) FR209602 and related compounds, novel antifungal lipopeptides from Coleophoma crateriformis no.738. I. Taxonomy, fermentation, isolation and physico-chemical properties. J Antibiot 59:137-144
77. Kanda M, Tsuboi M, Sakamoto K, Shimizu S, Yamashita M, Honda H (2009) Improvement of FR901379 production by mutant selection and medium optimization. J Biosci Bioeng 107:530-534
78. Kanda M, Yamamoto E, Hayashi A, Yabutani T, Yamashita M, Honda H (2010) Scale-up fermentation of echinocandin type antibiotic FR901379. J Biosci Bioeng 109:138-144
79. Katiyar S, Pfaller M, Edlind T (2006) Candida albicans and Candida glabrata clinical isolates exhibiting reduced echinocandin susceptibility. Antimicrob Agents Chemother 50:2892-2894
80. Katiyar SK, Edlind TD (2009) Role for Fks1 in the intrinsic echinocandin resistance of Fusarium solani as evidenced by hybrid expression in Saccharomyces cerevisiae. Antimicrob Agents Chemother 53:1772-1778
81. Katiyar SK, Alastruey-Izquierdo A, Healey KR, Johnson ME, Perlin DS, Edlind TD (2012) Fks1 and Fks2 are functionally redundant but differentially regulated in Candida glabrata: implications for echinocandin resistance. Antimicrob Agents Chemothe 56:6304-6309
82. Kauss H, Jeblick W (1986) Influence of free fatty acids, lysophosphatidylcholine, platelet-activating factor, acylcarnitine, and echinocandin B on 1,3-beta-D-glucan synthase and callose synthesis. Plant Physiol 80:7-13
83. Keller-Juslén C, Kuhn M, Loosli HR, Petcher TJ, Weber HP, von Wartburg A (1976) Struktur des cyclopeptid-antibiotikums sl 7810 (= echinocandinb). Tetrahedron Lett 17:4147-4150
84. Klein LL, Li L, Chen HJ, Curty CB, DeGoey DA, Grampovnik DJ, Leone CL, Thomas SA, Yeung CM, Funk KW, Kishore V, Lundell EO, Wodka D, Meulbroek JA, Alder JD, Nilius AM, Lartey PA, Plattner JJ (2000) Total synthesis and antifungal evaluation of cyclic aminohexapeptides. Bioorg Med Chem 8:1677-1696
85. Klich M, Mendoza C, Mullaney E, Keller N, Bennett JW (2001) A new sterigmatocystin-producing Emericella variant from agricultural desert soils. Syst Appl Microbiol 24:131-138
86. Kofla G, Ruhnke M (2011) Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis: review of the literature. Eur J Med Res 16:159-166
87. Kraas FI, Helmetag V, Wittmann M, Strieker M, Marahiel MA (2010) Functional dissection of surfactin synthetase initiation module reveals insights into the mechanism of lipoinitiation. Chem Biol 17:872-880
88. Kurtz MB, Douglas C, Marrinan J, Nollstadt K, Onishi J, Dreikorn S, Milligan J, Mandala S, Thompson J, Balkovec JM, Bouffard FA, Dropinski JF, Hammond ML, Zambias RA, Abruzzo G, Bartizal K, McManus OB, Garcia ML (1994a) Increased antifungal activity of L-733,560, a water-soluble, semisynthetic pneumocandin, is due to enhanced inhibition of cell wall synthesis. Antimicrob Agents Chemother 38:2750-2757
89. Kurtz MB, Heath IB, Marrinan J, Dreikorn S, Onishi J, Douglas C (1994b) Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activity against (1,3)-β-D-glucan synthase. Antimicrob Agents Chemother 38:1480-1489
90. Lal B, Gund VG, Gangopadhyay AK, Nadkarni SR, Dikshit V, Chatterjee DK, Shirvaikar R (2003) Semisynthetic modifications of hemiaminal function at ornithine unit of mulundocandin, towards chemical stability and antifungal activity. Bioorg Med Chem 11:5189-5198
91. Lamoth F, Juvvadi PR, Gehrke C, Steinbach WJ (2012) In vitro activity of calcineurin and heat-shock protein 90 (HSP90) inhibitors against Aspergillus fumigatus azole- and echinocandin-resistant strains. Antimicrob Agents Chemother. doi: 10.1128/AAC.01857-12
92. Lee KK, Maccallum DM, Jacobsen MD, Walker LA, Odds FC, Gow NA, Munro CA (2012) Elevated cell wall chitin in Candida albicans confers echinocandin resistance in vivo. Antimicrob Agents Chemother 56:208-217
93. Leonard WR Jr, Belyk KM, Conlon DA, Bender DR, DiMichele LM, Liu J, Hughes DL (2007) Synthesis of the antifungal beta-1,3-glucan synthase inhibitor CANCIDAS (caspofungin acetate) from pneumocandin B0. J Org Chem 72:2335-2343
94. Maligie MA, Selitrennikoff CP (2005) Cryptococcus neoformans resistance to echinocandins: (1,3)beta-glucan synthase activity is sensitive to echinocandins. Antimicrob Agents Chemother 49:2851-2856
95. Martos AI, Romero A, González MT, González A, Serrano C, Castro C, Pemán J, Cantón E, Martín-Mazuelos E (2010) Evaluation of the Etest method for susceptibility testing of Aspergillus spp. and Fusarium spp. to three echinocandins. Med Mycol 48:858-861
96. Masurekar PS, Fountoulakis JM, Hallada TC, Sosa MS, Kaplan L (1992) Pneumocandins from Zalerion arboricola. II. Modification of product spectrum by mutation and medium manipulation. J Antibiot 45:1867-1874
97. Mazur P, Morin N, Baginsky W, el Sherbeini M, Clemas JA, Nielsen JB, Foor F (1995) Differential expression and function of two homologous subunits of yeast 1,3-beta-D-glucan synthase. Mol Cell Biol 15:5671-5681
98. Mishra BB, Tiwari VK (2011) 1. Natural products in drug discovery: clinical evaluations and investigations. In: Tiwari VK, Mishra BB (eds) Opportunity, challenge and scope of natural products in medicinal chemistry. Research Signpost, Kerala, pp 1-62
99. Mizoguchi J, Saito T, Mizuno K, Hayano K (1977) On the mode of action of the new antifungal agent, aculeacin A: inhibition of cell wall synthesis in Saccharomyces cerevisiae. J Antibiot 30:308-313
100. Mizuno K, Yagi A, Satoi S, Takada M, Hayashi M, Asano K, Matsuda T (1977) Studies I. Isolation and characterization of aculeacin A. J Antibiot 30:297-302
101. Morris SA, Schwartz RE, Sesin DF, Masurekar P, Hallada TC, Schmatz DM, Bartizal K, Hensens OD, Zink DL (1994) Pneumocandin D0, a new antifungal agent and potent inhibitor of Pneumocystis carinii. J Antibiot 47:755-764
102. Mukherjee PK, Sheehan D, Puzniak L, Schlamm H, Ghannoum MA (2011) Echinocandins: are they all the same? J Chemother 23:319-325
103. Mukhopadhyay T, Ganguli BN, Fehlhaber HW, Kogler H, Verfesy L (1987) Mulundocandin, a new lipopeptide antibiotic. II. Structure elucidation. J Antibiot 40:281-289
104. Mukhopadhyay T, Roy K, Bhat RG, Sawant SN, Blumbach J, Gangtjli BN, Fehlhaber HW (1992) Deoxymulundocandin-A new echinocandin type antifungal antibiotic. J Antibiot 45:618-623
105. Niimi K, Maki K, Ikeda F, Holmes AR, Lamping E, Niimi M, Monk BC, Cannon RD (2006) Overexpression of Candida albicans CDR1, CDR2, or MDR1 does not produce significant changes in echinocandin susceptibility. Antimicrob Agents Chemother 50:1148-1155
106. Nobel HM, Langley D, Sidebottom PJ, Lane SJ, Fisher PJ (1991) An echinocandin from an endophytic Cryptosporiopsis sp. and Pezicula sp. In Pinus sylvestris and Fagus sylvatica. Mycol Res 95:1439-1440
107. Nyfeler R, Keller SW (1974) Metabolites of microorganisms, 143: echinocandin B, a novel polypeptide-antibiotic from Aspergillus nidulans var echinulatus - isolation and structural components. Helv Chim Acta 57:2459-2477
108. Odabasi Z, Paetznick V, Rex JH, Ostrosky-Zeichner L (2007) Effects of serum on in vitro susceptibility testing of echinocandins. Antimicrob Agents Chemother 51:4214-4216
109. Paderu P, Park S, Perlin DS (2004) Caspofungin uptake is mediated by a high-affinity transporter in Candida albicans. Antimicrob Agents Chemother 48:3845-3849
110. Paderu P, Garcia-Effron G, Balashov S, Delmas G, Park S, Perlin DS (2007) Serum differentially alters the antifungal properties of echinocandin drugs. Antimicrob Agents Chemother 51:2253-2256
111. Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD (2009) Infectious Diseases Society of America: Clinical Practice Guidelines for the management of candidiasis: update by the Infectious Diseases Society of America. Clin Infect Dis 48:503-535
112. Park S, Kelly R, Kahn JN, Robles J, Hsu MJ, Register E, Li W, Vyas V, Fan H, Abruzzo G, Flattery A, Gill C, Chrebet G, Parent SA, Kurtz M, Teppler H, Douglas CM, Perlin DS (2005) Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates. Antimicrob Agents Chemother 49:3264-3273
113. Perez P, Varona R, Garcia-Acha I, Duran A (1981) Effect of papulacandin B and aculeacin A on [Beta]-(1,3)-glucan-synthase from Geotrichum lactis. FEBS Lett 129:249-252
114. Perlin DS (2007) Resistance to echinocandin-class antifungal drugs. Drug Resist Updat 10:121-130
115. Perlin DS (2011) Current perspectives on echinocandin class drugs. Future Microbiol 6:441-457
116. Petersen LA, Hughes DL, Hughes R, DiMichele L, Salmon P, Connors N (2001) Effects of amino acid and trace element supplementation on pneumocandin production by Glarea lozoyensis: impact on titer, analogue levels, and the identification of new analogues of pneumocandin B(0). J Ind Microbiol Biotechnol 26:216-221
117. Petersen LA, Olewinski R, Salmon P, Connors N (2003) Novel proline hydroxylase activities in the pneumocandin-producing fungus Glarea lozoyensis responsible for the formation of trans 3- and trans 4-hydroxyproline. Appl Microbiol Biotechnol 62:263-267
118. Peterson SW (2008) Phylogenetic analysis of Aspergillus species using DNA sequences from four loci. Mycologia 100:205-226
119. Petraitiene R, Petraitis V, Groll AH, Candelario M, Sein T, Bell A, Lyman CA, McMillian CL, Bacher J, Walsh TJ (1999) Antifungal activity of LY303366, a novel echinocandin B, in experimental disseminated candidiasis in rabbits. Antimicrob Agents Chemother 43:2148-2155
120. Pfaller MA (2012) Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment. Am J Med 125:S3-S13
121. Pfaller MA, Diekema DJ (2009) Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20:133-163
122. Pfaller M, Riley J, Koerner T (1989) Effect of cilofungin (LY121019) on carbohydrate and sterol composition of Candida albicans. Eur J Clin Microbiol Infect Dis 8:1067-1070
123. Pfaller MA, Castanheira M, Messer SA, Moet GJ, Jones RN (2011a) Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans, and Aspergillus fumigatus: application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009). Diagn Microbiol Infect Dis 69:45-50
124. Pfaller MA, Diekema DJ, Andes D, Arendrup MC, Brown SD, Lockhart SR, Motyl M, Perlin DS, the CLSI Subcommittee for Antifungal Testing (2011b) Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria. Drug Resist Updat 14:164-176
125. Pfaller MA, Castanheira M, Lockhart SR, Ahlquist AM, Moet GJ, Messer SA, Woosley LN, Jones RN (2012) Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata: results from the SENTRY Antimicrobial Surveillance Program (2006-2010) and the Centers for Disease Control and Prevention Population-Based Surveillance (2008-2010). J Clin Microbiol. doi: 10.1128/JCM.06112-11
126. Plaine A, Walker L, Da Costa G, Mora-Montes HM, McKinnon A, Gow NA, Gaillardin C, Munro CA, Richard ML (2008) Functional analysis of Candida albicans GPI-anchored proteins: roles in cell wall integrity and caspofungin sensitivity. Fungal Genet Biol 45:1404-1414
127. Pollard DJ, Kirschner TF, Hernandez D, Hunt G, Olewinski R (2002) Pilot-scale process sensitivity studies for the scaleup of a fungal fermentation for the production of Pneumocandins. Biotechnol Bioeng 78:270-279
128. Pollard DJ, Kirschner TF, Hunt GR, Tong IT, Stieber R, Salmon PM (2007) Scale up of a viscous fungal fermentation. application of scale-up criteria with regime analysis and operating boundary conditions. Biotechnol Bioeng 96:307-317
129. Radding JA, Heidler SA, Turner W (1998) Photoaffinity analog of the semisynthetic echinocandin LY303366: identification of echinocandin targets in Candida albicans. Antimicrob Agents Chemother 42:1187-1194
130. Rank C, Nielsen KF, Larsen TO, Varga J, Samson RA, Frisvad JC (2011)
131. Rocha EM, Garcia-Effron G, Park S, Perlin DS (2007) A Ser678Pro substitution in Fks1p confers resistance to echinocandin drugs in Aspergillus fumigatus. Antimicrob Agents Chemother 51:4174-4176
132. Romano J, Nimrod G, Ben-Tal N, Shadkchan Y, Baruch K, Sharon H, Osherov N (2006) Disruption of the Aspergillus fumigatus ECM33 homologue results in rapid conidial germination, antifungal resistance and hypervirulence. Microbiology 152:1919-1928
133. Roy K, Mukhopadhyay T, Reddy GC, Desikan KR, Ganguli BN (1987) Mulundocandin, a new lipopeptide antibiotic. I. Taxonomy, fermentation, isolation and characterization. J Antibiot 40:275-280
134. Rüping MJGD, Vehreschild JJ, Cornely OA (2008) Patients at high risk of invasive fungal infections-when at how to treat. Drugs 68:1941-1962
135. Satoi S, Yagi A, Asano K, Mizuno K, Watanabe T (1977) Studies on aculeacin. II. Isolation and characterization of aculeacins B, C, D, E, F and G. J Antibiot 30:303-307
136. Sawistowska-Schröder ET, Kerridge D, Perry H (1984) Echinocandin inhibition of 1,3-beta-D-glucan synthase from Candida albicans. FEBS Lett 173:134-138
137. Schmatz DM, Abruzzo G, Powles MA, McFadden DC, Balkovec JM, Black RM, Nollstadt K, Bartizal K (1992) Pneumocandins from Zalerion arboricola. IV. Biological evaluation of natural and semisynthetic pneumocandins for activity against Pneumocystis carinii and Candida species. J Antibiot 45:1886-1891
138. Schwartz RE, Giacobbe RA, Bland JA, Monaghan RL (1989) L-671,329, a new antifungal agent. I. Fermentation and isolation. J Antibiot 42:163-167
139. Schwartz RE, Sesin DF, Joshua H, Wilson KE, Kempf AJ, Goklen KA, Kuehner D, Gailliot P, Gleason C, White R, Inamine E, Bills G, Salmon P, Zitano L (1992) Pneumocandins from Zalerion arboricola. Discovery and isolation I. J Antibiot 45:1853-1866
140. Scott LJ (2012) Micafungin: a review of its use in the prophylaxis and treatment of invasive Candida infections. Drugs 72:2141-2165
141. Shields RK, Nguyen MH, Press E, Clancy CJ (2011a) Five-minute exposure to caspofungin results in prolonged post-antifungal effects and eliminates the paradoxical growth of Candida albicans. Antimicrob Agents Chemother 55:3598-36023
142. Shields RK, Nguyen MH, Du C, Press E, Cheng S, Clancy CJ (2011b) Paradoxical effect of caspofungin against Candida bloodstream isolates is mediated by multiple pathways but eliminated in human serum. Antimicrob Agents Chemother 55:2641-2647
143. Singh SD, Robbins N, Zaas AK, Schell WA, Perfect JR, Cowen LE (2009) Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin. PLoS Pathog 5:e1000532
144. Singh-Babak SD, Babak T, Diezmann S, Hill JA, Xie JL, Chen YL, Poutanen SM, Rennie RP, Heitman J, Cowen LE (2012) Global analysis of the evolution and mechanism of echinocandin resistance in Candida glabrata. PLoS Pathog 8:e1002718
145. Sóczó G, Kardos G, Varga I, Kelentey B, Gesztelyi R, Majoros L (2007) In vitro study of Candida tropicalis isolates exhibiting paradoxical growth in the presence of high concentrations of caspofungin. Antimicrob Agents Chemother 51:4474-4476
146. Stevens DA, Ichinomiya M, Koshi Y, Horiuchi H (2006) Escape of Candida from caspofungin inhibition at concentrations above the MIC (paradoxical effect) accomplished by increased cell wall chitin; evidence for beta-1,6-glucan synthesis inhibition by caspofungin. Antimicrob Agents Chemother 50:3160-3161
147. Stone BA, Clarke AE (1992) The chemistry and biology of (13)-β-glucans. La Trobe University Press, Melbourne
148. Strobel GA, Miller RV, Martinez-Miller C, Condron MM, Teplow DB, Hess WM (1999) Cryptocandin, a potent antimycotic from the endophytic fungus Cryptosporiopsis cf. quercina. Microbiology 145:1919-1926
149. Szilágyi J, Földi R, Bayegan S, Kardos G, Majoros L (2012) Effect of nikkomycin Z and 50 % human serum on the killing activity of high-concentration caspofungin against Candida species using time-kill methodology. J Chemother 24:18-25
150. Taft CS, Stark T, Sellitrennikoff CP (1988) Cilofungin (LYI21019) inhibits Neurospora crassa growth and (1-3)-[Beta]-D-glucan synthase activity. J Antibiot 41:697-701
151. Takeshima H, Inokoshi J, Takada Y, Tanaka H, Omura S (1989) A deacylation enzyme for aculeacin A, a neutral lipopeptide antibiotic, from Actinoplanes utahensis: purification and characterization. J Biochem 105:606-610
152. Tang J, Parr TR (1991) W-1 solubilization and kinetics of inhibition by cilofungin of Candida albicans (1,3)-[Beta]-glucan synthase. Antimicrob Agents Chemother 35:99-103
153. Tkacz JS, Giacobbe RA, Monaghan RL (1993) Improvement in the titer of echinocandin-type antibiotics: a magnesium-limited medium supporting the biphasic production of pneumocandins A0 and B0. J Ind Microbiol 11:95-103
154. Torres-Bacete J, Hormigo D, Stuart M, Arroyo M, Torres P, Castillón MP, Acebal C, García JL, de la Mata I (2007) Newly discovered penicillin acylase activity of aculeacin A acylase from Actinoplanes utahensis. Appl Environ Microbiol 73:5378-5381
155. Tóth V (2012) Characterization of Aspergillus nidulans var. roseus ATCC 58397, investigation its echinocandin B and sterigmatocystin production. Dissertation, University of Debrecen
156. Tóth V, CsT N, Miskei M, Pócsi I, Emri T (2011) Polyphasic characterization of "Aspergillus nidulans var. roseus" ATCC 58397. Folia Microbiol 56:381-388
157. Tóth V, CsT N, Pócsi I, Emri T (2012) The echinocandin B producer fungus Aspergillus nidulans var. roseus ATCC 58397 does not possess innate resistance against its lipopeptide antimycotic. Appl Microbiol Biotechnol 95:113-122
158. Traber R, Keller-Juslén C, Loosli HR, Kuhn M, Von Wartburg A (1979) Cyclopeptid-Antibiotika aus Aspergillus-Arten. Struktur der Echinocandine C und D. Helv Chim Acta 62:1252-1267
159. Tscherter H, Dreyfuss MM (1982) New metabolites. Processes for their production and their use. Internat. Patent Appl PCT/EP8/00121
160. Ueda S, Sakamoto K, Oohata N, Tsuboi M, Yamashita M, Hino M, Yamada M, Hashimoto S (2010) Screening and characterization of microorganisms with FR901379 acylase activity. J Antibiot 63:65-70
161. Ueda S, Kinoshita M, Tanaka F, Tsuboi M, Shimizu S, Oohata N, Hino M, Yamada M, Isogai Y, Hashimoto S (2011a) Strain selection and scale-up fermentation for FR901379 acylase production by Streptomyces sp. no. 6907. J Biosci Bioeng 112:409-414
162. Ueda S, Shibata T, Ito K, Oohata N, Yamashita M, Hino M, Yamada M, Isogai Y, Hashimoto S (2011b) Cloning and expression of the FR901379 acylase gene from Streptomyces sp. no. 6907. J Antibiot 64:169-175
163. van de Sande WW, Fahal AH, Bakker-Woudenberg IA, van Belkum A (2010) Madurella mycetomatis is not susceptible to the echinocandin class of antifungal agents. Antimicrob Agents Chemother 54:2738-2740
164. van Duin D, Casadevall A, Nosanchuk JD (2002) Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibilities to amphotericin B and caspofungin. Antimicrob Agents Chemother 46:3394-3400
165. Vazquez JA, Lynch M, Sobel JD (1995) In vitro activity of a new pneumocandin antifungal agent, L-733,560 against azole-susceptible and -resistant Candida and Torulopsis species. Antimicrob Agents Chemother 39:2689-2691
166. Verwer PE, van Duijn ML, Tavakol M, Bakker-Woudenberg IA, van de Sande WW (2012) Reshuffling of Aspergillus fumigatus cell wall components chitin and β-glucan under the influence of caspofungin or nikkomycin Z alone or in combination. Antimicrob Agents Chemother 56:1595-1598
167. Walker LA, Munro CA, de Bruijn I, Lenardon MD, McKinnon A, Gow NA (2008) Stimulation of chitin synthesis rescues Candida albicans from echinocandins. PLoS Pathog 4(4):e1000040
168. Walker LA, Gow NAR, Munro CA (2010) Fungal echinocandin resistance. Fungal Genet Biol 47:117-126
169. Walker LA, Gow NA, Munro CA (2012) Elevated chitin content reduces the susceptibility of Candida species to caspofungin. Antimicrob Agents Chemother. doi: 10.1128/AAC.01486-12
170. Wiederhold NP (2007) Attenuation of echinocandin activity at elevated concentrations: a review of the paradoxical effect. Curr Opin Infect Dis 20:574-578
171. Wittmann M, Linne U, Pohlmann V, Marahiel MA (2008) Role of DptE and DptF in the lipidation reaction of daptomycin. FEBS J 275:5343-5354
172. Yamaguchi H, Hiratani T, Iwata K, Yamamoto Y (1982) Studies on the mechanism of antifungal action of aculeacin A. J Antibiot 35:210-219
173. Yamaguchi H, Hiratani T, Baba MN, Osumi M (1985) Effect of aculeacin A, a wall-active antibiotic, on synthesis of the yeast cell wall. Microbiol Immunol 29:609-623
174. Yao J, Liu H, Zhou T, Chen H, Miao Z, Sheng C, Zhang W (2012) Total synthesis and structure-activity relationships of new echinocandin-like antifungal cyclolipohexapeptides. Eur J Med Chem 50:196-208
175. Youssar L, Grüning BA, Erxleben A, Günther S, Hüttel W (2012) Genome sequence of the fungus Glarea lozoyensis: the first genome sequence of a species from the Helotiaceae family. Eukaryot Cell 11:250, Erratum in: Eukaryot Cell 11:829
176. Zambias RA, Hammond ML, Heck JV, Bartizal K, Trainor C, Abruzzo G, Schmatz DM, Nollstadt KM (1992) Preparation and structure relationships of simplified analogues of the antifungal agent cilofungin: a total synthesis approach. J Med Chem 35:2843-2855